Hepatic encephalopathy

被引：24

作者：

Ong, JP ^{[1
]}

Mullen, KD ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA

来源：

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2001年 / 13卷 / 04期

关键词：

ammonia; benzodiazepine; cirrhosis; GABA; hepatic encephalopathy; pathogenesis; treatment;

D O I：

10.1097/00042737-200104000-00005

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In the last decade, a significant amount of research has been devoted to the pathogenesis and treatment of hepatic encephalopathy (HE), Non-invasive neuroimaging techniques such as magnetic resonance imaging and spectroscopy have become important research tools. The search for a suitable animal model of HE associated with cirrhosis is still ongoing, Moreover, consensus terminology and diagnostic criteria for HE in humans are badly needed, Eur J Gastroenterol Hepatol 13:325-334 (C) 2001 Lippincott Williams & Wilkins.

引用

页码：325 / 334

页数：10

共 170 条

[1]

ALMARDINI H, 1993, HEPATOLOGY, V17, P1033

[2] The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study [J].

Amodio, P ;

Marchetti, P ;

DelPiccolo, F ;

Beghi, A ;

Comacchio, F ;

Carraro, P ;

Campo, G ;

Baruzzo, L ;

Marchiori, C ;

Gatta, A .

CLINICAL PHYSIOLOGY, 1997, 17 (05) :533-539

[3] Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts [J].

Aronson, LR ;

Gacad, RC ;

KaminskyRuss, K ;

Gregory, CR ;

Mullen, KD .

VETERINARY SURGERY, 1997, 26 (03) :189-194

[4] Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy [J].

Avallone, R ;

Zeneroli, ML ;

Venturini, I ;

Corsi, L ;

Schreier, P ;

Kleinschnitz, M ;

Ferrarese, C ;

Farina, F ;

Baraldi, C ;

Pecora, N ;

Frigo, M ;

Baraldi, M .

GUT, 1998, 42 (06) :861-867

[5] Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An Italian multicenter double-blind, placebo-controlled, cross-over study [J].

Barbaro, G ;

Di Lorenzo, G ;

Soldini, M ;

Giancaspro, G ;

Bellomo, G ;

Belloni, G ;

Grisorio, B ;

Annese, M ;

Bacca, D ;

Francavilla, R ;

Barbarini, G .

HEPATOLOGY, 1998, 28 (02) :374-378

[6] Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy [J].

Basile, AS ;

Jones, EA .

HEPATOLOGY, 1997, 25 (06) :1303-1305

[7]

Bengtsson F, 1996, ADV EXP MED BIOL, V398, P387

[8] AROMATIC AND BRANCHED-CHAIN AMINO-ACIDS IN AUTOPSIED BRAIN-TISSUE FROM CIRRHOTIC-PATIENTS WITH HEPATIC-ENCEPHALOPATHY [J].

BERGERON, M ;

LAYRARGUES, GP ;

BUTTERWORTH, RF .

METABOLIC BRAIN DISEASE, 1989, 4 (03) :169-176

[9] REGIONAL ALTERATIONS OF DOPAMINE AND ITS METABOLITES IN RAT-BRAIN FOLLOWING PORTACAVAL ANASTOMOSIS [J].

BERGERON, M ;

SWAIN, MS ;

READER, TA ;

BUTTERWORTH, RF .

NEUROCHEMICAL RESEARCH, 1995, 20 (01) :79-86

[10] Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: Implications for thymoleptic drug safety in liver insufficiency [J].

Bergqvist, PBF ;

Wikell, C ;

Hjorth, S ;

Apelqvist, G ;

Bengtsson, F .

CLINICAL NEUROPHARMACOLOGY, 1997, 20 (06) :511-522

← 1 2 3 4 5 6 7 8 9 10 →